Market Pathways Scorecard: EUDAMED Snapshot
An infographic look at what has been entered in the EU's EUDAMED database so far as the May 28 date for mandatory registration of certificates, devices, companies, and more approaches.
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
An infographic look at what has been entered in the EU's EUDAMED database so far as the May 28 date for mandatory registration of certificates, devices, companies, and more approaches.
Breast cancer is highly manageable when caught early, yet clinicians still face challenges: patient stratification after screening isn’t precise enough, and surgical outcomes could be improved. We spoke with Clairity, Cairn Surgical, and Resilient Medical—innovators working to raise the standard of care for this disease that predominantly affects women.
Pulsed field ablation is set to supplant radiofrequency and cryoablation as the preferred catheter-based approach to stopping arrhythmias. Because it is safer and faster than older technologies, it is helping electrophysiologists treat more patients and accelerate the overall growth of the cardiac ablation business. Excerpted from our recent feature, "PFA Is Ready to Electrify the Electrophysiology Market."